{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:24:31Z","timestamp":1791429871786,"version":"4.3.3"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.vaccine.2022.12.048","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T15:16:28Z","timestamp":1672240588000},"page":"938-944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Engineering of a plant-produced virus-like particle to improve the display of the Plasmodium falciparum Pfs25 antigen and transmission-blocking activity of the vaccine candidate"],"prefix":"10.1016","volume":"41","author":[{"given":"Stephen","family":"Tottey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mark Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Musiychuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Chichester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoyo","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shwu-Maan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Plieskatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Streatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidadi","family":"Yusibov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.12.048_b0005","unstructured":"WHO. World Malaria Report 2020. Geneva: World Health Organization."},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2022.12.048_b0010","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1186\/1471-2458-11-S3-S14","article-title":"Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved Tool","volume":"11","author":"Thwing","year":"2011","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2022.12.048_b0015","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/ciw388","article-title":"Declining efficacy of artemisinin combination therapy against P. Falciparum malaria on the Thai-Myanmar border (2003\u20132013): the role of parasite genetic factors","volume":"63","author":"Phyo","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2022.12.048_b0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.12.048_b0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/bs.apar.2015.04.001","article-title":"Development of malaria transmission-blocking vaccines: from concept to product","volume":"89","author":"Wu","year":"2015","journal-title":"Adv Parasitol"},{"issue":"6168","key":"10.1016\/j.vaccine.2022.12.048_b0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/333074a0","article-title":"A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains","volume":"333","author":"Kaslow","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.12.048_b0035","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1084\/jem.162.5.1460","article-title":"Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito","volume":"162","author":"Vermeulen","year":"1985","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2022.12.048_b0040","first-page":"91","article-title":"Plasmodium falciparum transmission blocking monoclonal antibodies recognize monovalently expressed epitopes","volume":"62","author":"Vermeulen","year":"1985","journal-title":"Dev Biol Stand"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.048_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01924-3","article-title":"Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25","volume":"8","author":"Scally","year":"2017","journal-title":"Nat Commun"},{"issue":"52","key":"10.1016\/j.vaccine.2022.12.048_b0050","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1016\/j.vaccine.2015.08.073","article-title":"Transmission blocking malaria vaccines: assays and candidates in clinical development","volume":"33","author":"Sauerwein","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2022.12.048_b0055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nbt0594-494","article-title":"Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose","volume":"12","author":"Kaslow","year":"1994","journal-title":"Biotechnology (N Y)"},{"key":"10.1016\/j.vaccine.2022.12.048_b0060","doi-asserted-by":"crossref","unstructured":"Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, et al. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS One. 2008;3:e2636.","DOI":"10.1371\/journal.pone.0002636"},{"issue":"9","key":"10.1016\/j.vaccine.2022.12.048_b0065","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1473-3099(18)30344-X","article-title":"Safety and immunogenicity of Pfs25H-EPA\/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults","volume":"18","author":"Sagara","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2022.12.048_b0070","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1074\/jbc.272.10.6428","article-title":"Glycosylphosphatidylinositol anchors represent the major carbohydrate modification in proteins of intraerythrocytic stage Plasmodium falciparum","volume":"272","author":"Gowda","year":"1997","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.048_b0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4161\/hv.34366","article-title":"A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses","volume":"11","author":"Jones","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.12.048_b0080","doi-asserted-by":"crossref","unstructured":"Jones RM, Chichester JA, Mett V, Jaje J, Tottey S, Manceva S, et al. A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice. PLoS One. 2013;8:e79538.","DOI":"10.1371\/journal.pone.0079538"},{"issue":"8","key":"10.1016\/j.vaccine.2022.12.048_b0085","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1128\/CVI.05105-11","article-title":"A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparum","volume":"18","author":"Farrance","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.048_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-016-1464-6","article-title":"Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates","volume":"15","author":"Lee","year":"2016","journal-title":"Malar J"},{"issue":"27","key":"10.1016\/j.vaccine.2022.12.048_b0095","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.vaccine.2010.04.036","article-title":"The IC(50) of anti-Pfs25 antibody in membrane-feeding assay varies among species","volume":"28","author":"Cheru","year":"2010","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.vaccine.2022.12.048_b0100","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1016\/j.vaccine.2018.08.033","article-title":"Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults","volume":"36","author":"Chichester","year":"2018","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2022.12.048_b0105","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.vaccine.2008.11.108","article-title":"Plant-derived hemagglutinin protects ferrets against challenge infection with the A\/Indonesia\/05\/05 strain of avian influenza","volume":"27","author":"Shoji","year":"2009","journal-title":"Vaccine"},{"issue":"sup1","key":"10.1016\/j.vaccine.2022.12.048_b0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4161\/hv.7.0.14588","article-title":"Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity","volume":"7","author":"Farrance","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2022.12.048_b0115","doi-asserted-by":"crossref","unstructured":"Miura K, Deng B, Tullo G, Diouf A, Moretz SE, Locke E, et al. Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays. PLoS One. 2013;8:e57909.","DOI":"10.1371\/journal.pone.0057909"},{"issue":"8","key":"10.1016\/j.vaccine.2022.12.048_b0120","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.tplants.2005.07.002","article-title":"Plant virus transport: motions of functional equivalence","volume":"10","author":"Scholthof","year":"2005","journal-title":"Trends Plant Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.048_b0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0042-6822(92)90215-B","article-title":"The coat protein of white clover mosaic potexvirus has a role in facilitating cell-to-cell transport in plants","volume":"191","author":"Forster","year":"1992","journal-title":"Virology"},{"issue":"18","key":"10.1016\/j.vaccine.2022.12.048_b0130","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1002\/j.1460-2075.1996.tb00888.x","article-title":"A plant viral coat protein RNA binding consensus sequence contains a crucial arginine","volume":"15","author":"Ansel-McKinney","year":"1996","journal-title":"EMBO J"},{"issue":"8","key":"10.1016\/j.vaccine.2022.12.048_b0135","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1094\/MPMI-04-12-0079-R","article-title":"Multifunctional roles for the N-terminal basic motif of Alfalfa mosaic virus coat protein: nucleolar\/cytoplasmic shuttling, modulation of RNA-binding activity, and virion formation","volume":"25","author":"Herranz","year":"2012","journal-title":"Mol Plant Microbe Interact"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.048_b0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/viro.1995.1168","article-title":"N-terminal basic amino acids of alfalfa mosaic virus coat protein involved in the initiation of infection","volume":"208","author":"Yusibov","year":"1995","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2022.12.048_b0145","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1006\/viro.1994.1411","article-title":"Early and late functions of alfalfa mosaic virus coat protein can be mutated separately","volume":"202","author":"Van Der Vossen","year":"1994","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.048_b0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0022-2836(77)90044-4","article-title":"Alfalfa mosaic virus protein polymerization","volume":"113","author":"Driedonks","year":"1977","journal-title":"J Mol Biol"},{"issue":"10","key":"10.1016\/j.vaccine.2022.12.048_b0155","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1128\/jvi.71.10.7911-7916.1997","article-title":"The structure of alfalfa mosaic virus capsid protein assembled as a T=1 icosahedral particle at 4.0-A resolution","volume":"71","author":"Kumar","year":"1997","journal-title":"J Virol"},{"issue":"Suppl 6","key":"10.1016\/j.vaccine.2022.12.048_b0160","doi-asserted-by":"crossref","first-page":"G67","DOI":"10.1016\/j.vaccine.2009.10.013","article-title":"Development of the RTS, S\/AS malaria candidate vaccine","volume":"27","author":"Vekemans","year":"2009","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.vaccine.2022.12.048_b0165","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1016\/j.vaccine.2016.05.007","article-title":"Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax","volume":"34","author":"Blagborough","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.12.048_b0170","doi-asserted-by":"crossref","first-page":"e1006108","DOI":"10.1371\/journal.ppat.1006108","article-title":"Probability of Transmission of Malaria from Mosquito to Human Is Regulated by Mosquito Parasite Density in Naive and Vaccinated Hosts","volume":"13","author":"Churcher","year":"2017","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:21:33Z","timestamp":1759404093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22015730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0264410X22015730"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering of a plant-produced virus-like particle to improve the display of the Plasmodium falciparum Pfs25 antigen and transmission-blocking activity of the vaccine candidate","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}